• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期多模式治疗在腹膜假黏液瘤患者中的应用:三级中心首例患者的治疗报告

Application of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center.

作者信息

Khan Arshad Bashir, Al Suhaibani Youssuf, Al Mohaimed Khaled, Morris David L

出版信息

Indian J Surg Oncol. 2010 Sep;1(3):270-3. doi: 10.1007/s13193-010-0036-4. Epub 2010 Dec 23.

DOI:10.1007/s13193-010-0036-4
PMID:22693376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3244241/
Abstract

Pseudomyxoma peritonei following dissemination of appendicealmucinous neoplasms is slowly progressive but inevitably a lethal condition. It is locally invasive and does not lead to lymph node or distant metastasis making it amenable for more radical procedures. We present a case of pseudomyxoma peritonei treated by Cytoreductive surgery(CRS)and heated intraperitoneal chemotherapy(HIPEC) with Mitomycin C (12.5mg/m2 ) at 41.50 C. This was followed by five cycles of early postoperative intraperitoneal chemotherapy (EPIC) with 5FU (650 mg/m2) over 5 days. Patient underwent standard Peritonectomy procedure combined with resection of gallbladder, Spleen, subtotal colectomy and resection of part of small bowel. Blood loss during theprocedure was 4000ml. Histopathology revealed Pseudomyxoma peritonei (hybrid type). The patient recuperated well and was discharged and now is living a productive life. Peritonectomy with perioperative intraperitoneal chemotherapy is the current standard of treatment for appendiceal tumors with peritoneal dissemination which offers a hope of disease free long survival in such patients.

摘要

阑尾黏液性肿瘤播散后引起的腹膜假黏液瘤进展缓慢,但最终会致命。它具有局部侵袭性,不会导致淋巴结转移或远处转移,因此适合采用更彻底的手术治疗。我们报告一例腹膜假黏液瘤患者,接受了细胞减灭术(CRS)及术中41.50℃热灌注化疗(HIPEC),使用丝裂霉素C(12.5mg/m²)。术后早期又进行了5个周期的腹腔内化疗(EPIC),使用5-氟尿嘧啶(5FU,650mg/m²),持续5天。患者接受了标准的腹膜切除术,同时切除了胆囊、脾脏、次全结肠切除术及部分小肠切除术。手术中失血4000ml。组织病理学检查显示为腹膜假黏液瘤(混合型)。患者恢复良好并出院,现在过着充实的生活。对于阑尾肿瘤伴腹膜播散患者,围手术期腹腔内化疗的腹膜切除术是目前的标准治疗方法,有望使此类患者长期无病生存。

相似文献

1
Application of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center.晚期多模式治疗在腹膜假黏液瘤患者中的应用:三级中心首例患者的治疗报告
Indian J Surg Oncol. 2010 Sep;1(3):270-3. doi: 10.1007/s13193-010-0036-4. Epub 2010 Dec 23.
2
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.阑尾来源的假性黏液瘤行细胞减灭术(CRS)和腹腔内热灌注化疗(HIPEC):单中心研究结果。
Updates Surg. 2020 Dec;72(4):1207-1212. doi: 10.1007/s13304-020-00788-5. Epub 2020 May 14.
3
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.细胞减灭术及围手术期腹腔内化疗作为腹膜假黏液瘤综合征的一种根治性治疗方法。
Eur J Surg Oncol. 2001 Apr;27(3):239-43. doi: 10.1053/ejso.2000.1038.
4
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.根治性细胞减灭术和腹腔内热灌注化疗治疗阑尾来源的假性黏液瘤腹膜假性黏液瘤的可行性。
Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.
5
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: A single-center experience.细胞减灭术及腹腔内热灌注化疗治疗腹膜假黏液瘤:单中心经验
Indian J Gastroenterol. 2017 Nov;36(6):452-458. doi: 10.1007/s12664-017-0799-4. Epub 2017 Nov 29.
6
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.减瘤手术与热灌注腹腔化疗治疗腹膜假黏液瘤和阑尾肿瘤
Indian J Surg Oncol. 2016 Jun;7(2):166-76. doi: 10.1007/s13193-015-0478-9. Epub 2015 Oct 24.
7
Management of an inguinal hernia in patients with pseudomyxoma peritonei.腹膜假黏液瘤患者腹股沟疝的管理
Eur J Surg Oncol. 2017 Jun;43(6):1083-1087. doi: 10.1016/j.ejso.2016.12.005. Epub 2017 Jan 6.
8
Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.黏液性腹膜假黏液瘤综合征患者黏液性肿瘤的胸膜播散
Ann Surg Oncol. 2000 Apr;7(3):199-203. doi: 10.1007/BF02523654.
9
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.46例腹膜假黏液瘤综合征患者的组织病理学分析:二次探查手术的失败与成功情况
Mod Pathol. 2001 Mar;14(3):164-71. doi: 10.1038/modpathol.3880276.
10
Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.细胞减灭术联合腹腔热灌注化疗(HIPEC)治疗腹膜假黏液瘤:十二年经验的结果分析
In Vivo. 2009 Jul-Aug;23(4):639-44.

引用本文的文献

1
Enteral nutrition provides favorable postoperative outcomes for patients with pseudomyxoma peritonei: a retrospective study.肠内营养为腹膜假黏液瘤患者提供良好的术后预后:一项回顾性研究。
Gland Surg. 2022 May;11(5):818-825. doi: 10.21037/gs-22-170.
2
The "homemade" HIPEC machine - a cost-effective alternative in low-resource countries.“自制”的腹腔热灌注化疗(HIPEC)机器——低资源国家中一种经济高效的替代方案。
Pleura Peritoneum. 2017 Dec 1;2(4):163-170. doi: 10.1515/pp-2017-0022. Epub 2017 Nov 2.
3
Pseudomyxoma Peritonei: Case Report and Literature Review.腹膜假黏液瘤:病例报告及文献综述
J Gastrointest Cancer. 2019 Dec;50(4):1037-1042. doi: 10.1007/s12029-018-00192-8.

本文引用的文献

1
Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.阑尾源性腹膜假黏液瘤综合征概述
Clin J Oncol Nurs. 2007 Aug;11(4):525-32. doi: 10.1188/07.CJON.525-532.
2
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?阑尾上皮性肿瘤和腹膜假黏液瘤综合征的新治疗标准?
Lancet Oncol. 2006 Jan;7(1):69-76. doi: 10.1016/S1470-2045(05)70539-8.
3
The etiology, clinical presentation, and management of pseudomyxoma peritonei.腹膜假黏液瘤的病因、临床表现及治疗
Surg Oncol Clin N Am. 2003 Jul;12(3):585-603. doi: 10.1016/s1055-3207(03)00026-7.
4
Pseudomyxoma peritonei.腹膜假黏液瘤
Nurs Times. 2003;99(39):30-2.
5
Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy.在接受细胞减灭术和腹腔热灌注化疗的腹膜假黏液瘤患者中,基线及系列癌胚抗原和糖类抗原19.9测量值的预后价值
Ann Surg Oncol. 2002 Dec;9(10):961-7. doi: 10.1007/BF02574513.
6
Review of a personal experience in the management of carcinomatosis and sarcomatosis.癌病和肉瘤病治疗个人经验回顾
Jpn J Clin Oncol. 2001 Dec;31(12):573-83. doi: 10.1093/jjco/hye088.
7
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.细胞减灭术及围手术期腹腔内化疗作为腹膜假黏液瘤综合征的一种根治性治疗方法。
Eur J Surg Oncol. 2001 Apr;27(3):239-43. doi: 10.1053/ejso.2000.1038.
8
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique.采用大剧场技术进行的200例细胞减灭术及术中腹腔内热灌注化疗治疗的发病率和死亡率分析。
Ann Surg Oncol. 1999 Dec;6(8):790-6. doi: 10.1007/s10434-999-0790-0.
9
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.385例阑尾恶性肿瘤腹膜表面播散患者的治疗结果。
Ann Surg Oncol. 1999 Dec;6(8):727-31. doi: 10.1007/s10434-999-0727-7.
10
Successful management of microscopic residual disease in large bowel cancer.大肠癌微小残留病的成功管理。
Cancer Chemother Pharmacol. 1999;43 Suppl:S15-25. doi: 10.1007/s002800051093.